Sotorasib for Lung Cancers with KRAS p.G12C Mutation
Abstract BACKGROUND Sotorasib showed anticancer activity in patients with KRAS p.G12C–mutated advanced solid tumors in a phase 1 study, and particularly promising anticancer activity was observed in